1 Cox N J, Tamblyn S E, Tam T. Influenza pandemic planning. Vaccine, 2003, 21: 1801-1803
[2]
2 Hehme N, Engelmann H, Künzel W, et al. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med Microbiol Immunol, 2002, 191: 203-208
[3]
3 El Zowalaty M E, Bustin S A, Husseiny M I, et al. Avian influenza: virology, diagnosis and surveillance. Future Microbiol, 2013, 8: 1209-1227
[4]
4 Garten R J, Davis C T, Russell C A, et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science, 2009, 325: 197-201
[5]
5 Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med, 2013, 368: 1888-1897
[6]
13 Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet, 2013, 381: 1916-1925
[7]
14 Li Q, Zhou L, Zhou M, et al. Preliminary report: epidemiology of the avian influenza A (H7N9) outbreak in China. N Engl J Med, 2013 Apr 24.[Epub ahead of print]
[8]
15 Zhou J, Wang D, Gao R, et al. Biological features of novel avian influenza A (H7N9) virus. Nature, 2013, 499: 500-503
[9]
16 Zhang Q, Shi J, Deng G, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science, 2013, 341: 410-414
[10]
17 Bao C J, Cui L B, Zhou M H, et al. Live-animal markets and influenza A (H7N9) virus infection. New Engl J Med, 2013, 368: 2337-2339
[11]
18 Xu J, Lu S, Wang H, et al. Reducing exposure to avian influenza H7N9. Lancet, 2013, 381: 1815-1816
[12]
19 Cowling B J, Jin L, Lau E H, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet, 2013, 382: 129-137
[13]
20 Zhang W, Shi Y, Lu X, et al. An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science, 2013, 340: 1463-1467
[14]
6 Yu H, Cowling B J, Feng L, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet, 2013, 382: 138-145
[15]
7 Gao H N, Lu H Z, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med, 2013, 368: 2277-2285
[16]
8 Taubenberger J K, Reid A H, Fanning T G. The 1918 influenza virus: a killer comes into view. Virology, 2000, 274: 241-245
[17]
9 Taubenberger J K, Reid A H, Krafft A E, et al. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science, 1997, 275: 1793-1796
[18]
10 Mounts A W, Kwong H, Izurieta H S, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis, 1999, 180: 505-508
[19]
11 Lupiani B, Reddy S M. The history of avian influenza. Comp Immunol Microbiol Infect Dis, 2009, 32: 311-323
[20]
21 韦平, 秦爱建. 重要动物病毒分子生物学. 北京: 科学出版社, 2008. 3-27
[21]
22 Galloway S E, Reed M L, Russell C J, et al. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog, 2013, 9: e1003151
[22]
23 Senne D A, Panigrahy B, Kawaoka Y et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis, 1996, 40: 425-437
[23]
24 Alexander D J. An overview of the epidemiology of avian influenza. Vaccine, 2007, 25: 5637-5644
[24]
25 Gohrbandt S, Veits J, Hundt J, et al. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. J Gen Virol, 2011, 92: 51-59
[25]
26 Seo S H, Hoffmann E, Webster R G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med, 2002, 8: 950-954
[26]
27 Fauci A S. Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell, 2006, 124: 665-670
[27]
28 Swayne D E, Suarez D L. Highly pathogenic avian influenza. Rev Sci Tech, 2000, 19: 463-482
[28]
29 Suarez D L, Das A, Ellis E. Review of rapid molecular diagnostic tools for avian influenza virus. Avian Dis, 2007, 51: 201-208
[29]
30 刘建伟, 唐博恒, 刘金华. 人流感与禽流感. 现代医院, 2013, 13: 10-12
[30]
31 Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet, 2013, 381: 2273-2279
[31]
12 Liu D, Shi W, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet, 2013, 381: 1926-1932
